Metaphore Biotechnologies
Ben Goldberg is currently employed at Metaphore Biotechnologies as a Scientist II in Discovery Sciences and Technology. Prior to this, Ben served as a Graduate Research Assistant at Thayer School of Engineering at Dartmouth and University of Florida, where Ben conducted research for their Ph.D. and Master's degree, respectively. Ben also has experience as a Laboratory Technician at University of Florida and as an Upstream Bioprocessing R&D Intern at Nanotherapeutics, Inc. Ben's educational background includes a Doctor of Philosophy in Bioengineering and Biomedical Engineering from Dartmouth College, a Master of Science in Translational Biotechnology from University of Florida, and a Bachelor of Science in Biology and Philosophy from Boston College.
This person is not in any offices
Metaphore Biotechnologies
Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact. Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.